Trials / Completed
CompletedNCT06029413
Myo vs. Myofascial Injection for Myofascial Trigger Points
Myo Vs. Myofascial Injection for Myofascial Trigger Points. Is There Really a Difference? A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Bozyaka Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.
Detailed description
This study aims to compare the intramuscular trigger point injection, which is traditionally used in the treatment of myofascial trigger points with the method in which facial layers are also included in the application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | myo + fascial injection | 10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as well as for fascial layers as described. |
| PROCEDURE | traditional trigger point injection | 10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as described. |
Timeline
- Start date
- 2023-09-26
- Primary completion
- 2024-07-25
- Completion
- 2024-07-25
- First posted
- 2023-09-08
- Last updated
- 2024-08-28
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06029413. Inclusion in this directory is not an endorsement.